Published in Vaccine Weekly, July 25th, 2007
This direction in AIDS vaccine development is crucial: Today, most candidates in clinical trials—numbering close to 30—are based on a cell-mediated approach, targeting only one arm of the human immune system. Promising vectors that trigger mucosal immunity at the primary site of infection and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly